This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Background Heartfailure with preserved ejection fraction is a recognised outcome in patients with myocardial infarction, although heartfailure with reduced ejection fraction is more common. fold higher risk of heartfailure with preserved ejection fraction (95% CI 1.30 m/s had a 2.10-fold m/s had a 2.10-fold
Bicuspid aorticvalve (BAV), the most common congenital cardiac anomaly, predisposes individuals to aortic stenosis and regurgitation due to valve degeneration. We performed repair of the rupture and concomitant ascending aorta replacement to prevent further exacerbation of the patient's condition.
Heartfailure (HF) is one of the significant complications in patients with myocardial infarction (MI), leading to increased risk for cardiovascular morbidity and mortality. 2 However, mortality rate is greater in HF cases developing >3 days following MI compared with less than or equal to 3 days after MI.
Getty Images milla1cf Mon, 01/29/2024 - 14:24 January 29, 2024 — Despite national guidelines recommending surgical aorticvalve replacement (SAVR) for patients under age 65 with severe aortic stenosis , many hospitals are still opting for a nonsurgical approach in patients under 60—possibly with poorer survival rates.
The goal of the TAVR UNLOAD trial was to evaluate transcatheter aorticvalve replacement (TAVR) compared with clinical surveillance among patients with chronic systolic heartfailure and moderate aortic stenosis (stage B aortic stenosis).
Findings from the TAVR UNLOAD study found limited benefits of transcatheter aorticvalve replacement (TAVR) in the treatment of heartfailure (HF) with reduced ejection fraction (HFrEF) and moderate aortic stenosis (AS).
Background Closure of paravalvular leak (PVL) regurgitation after self-expandable (SE) transcatheter aorticvalve implantation (TAVI) may be more challenging than after balloon-expandable (BE) valve implantation. The patient was deemed to be at prohibitive surgical risk and a catheter-based PVL closure procedure was planned.
TAVR in heartfailure. ABSTRACT Patients with severe aortic stenosis (AS) may develop heartfailure (HF), the presence of which has traditionally been deemed as a final stage in AS progression with poor outcomes.
Objective The association between a combined anaemia and renal failure index and 1-year prognosis of patients undergoing transcatheter aorticvalve implantation (TAVI) is unexplored. The primary clinical outcome measure was all-cause mortality and heartfailure hospitalisation 1 year after TAVI. 95% CI 2.21
(MedPage Today) -- CHICAGO -- Dapagliflozin (Farxiga) lowered mortality and heartfailure worsening in high-risk older adults getting transcatheter aorticvalve implantation (TAVI), the DapaTAVI trial showed. In a population with a history of.
Edwards Lifesciences is going all-in on structural heart and heartfailure, acquiring aorticvalve-maker JenaValve Technology and implantable heartfailure monitor company Endotronix for $1.2B and up to $445M in milestone payments.
Proposed approach for clinical management and therapeutic optimization in patients with heartfailure with reduced ejection fraction and low blood pressure. Low blood pressure with major or mild symptoms. **SBP SBP <80mmHg or symptomatic low BP or asymptomatic low BP.
Clinical introduction A woman in her 60s with non-obstructive coronary artery disease, aorticvalve replacement and aortic arch repair, chronic diastolic heartfailure and paroxysmal atrial fibrillation (AF) and flutter (AFL), presented with 3 days of sustained palpitations that felt similar to prior episodes of AF/AFL.
Backgrounds Permanent pacemaker implantation (PPMI) is one of the greatest disadvantages of transcatheter aorticvalve implantation (TAVI). Methods We retrospectively analysed data from 745 consecutive patients who underwent TAVI for severe aortic stenosis from November 2013 to July 2022. vs 9.1%±9.7%; p=0.035).
Joint Statement on AorticValve Replacement in Low-Risk Patients Issued by Society of Thoracic Surgeons and European Association for Cardiothoracic Surgeons 6. STOP-CA Clinical Trial Finds Statins Lower Rate of Heart Decline in Lymphoma Patients, Late-Breaking ACC23 Clinical Trial Reports 7.
BACKGROUND:The extent of cardiac damage has been shown to be associated with increased mortality, repeat hospitalization, and decreased quality of life after aorticvalve replacement (AVR). Circulation: Cardiovascular Interventions, Ahead of Print.
ET Murphy Ballroom 4 ACC.24 24 planners note that attendees can gain insights from key clinical trials presented at ACC.24 24 and how those may impact clinical practice and patient care in this deep dive clinical trial session.
Stress hyperglycemia ratio (SHR) has recently been recognized as a novel biomarker that accurately reflects acute hyperglycemia status and is associated with poor prognosis of heartfailure. We evaluated the r.
This study aimed to examine the impact of severe MR on outcomes in paradoxical low-flow, low-gradient severe aortic stenosis.METHODS:Data from an institutional echo database identified 1189 patients with adjudicated severe aortic stenosis (aorticvalve area 1.0 Subgroups were based on MR severity (severe and nonsevere).
Patients with significant pulmonary oedema or aorticvalve (AV) closure during venoarterial extracorporeal membrane oxygenation (VA-ECMO) were randomized to early left ventricular (LV) unloading or conventional strategy groups (1:1). The primary endpoint was the rate of weaning from VA-ECMO during index admission.
Bar plots: in red, patients with low flow-low gradient (LF-LG) aortic stenosis; in blue, patients with normal flow-high gradient (HG) aortic stenosis; in black: controls. Aim Cardiac remodelling plays a major role in the prognosis of patients with aortic stenosis (AS) and could impact the benefits of aorticvalve replacement.
An Aortic Impella device, that is distal to the aorticvalve and devoid of LV-related issues. The innovators and engineers of new-age mechanical assist systems could learn a few crucial insights from these unique and humble animal beings. Shall we think about,axial pumps in ascending Aorta in series with LV.
The diagnostic coronary angiogram identified only minimal coronary artery disease, but there was a severely calcified, ‘immobile’ aorticvalve. Aortic angiogram did not reveal aortic dissection. If you see this, you should Doppler the valve. Aorticvalve surgery as an emergency procedure.
A 70-year-old female patient with a history of bioprosthetic aorticvalve replacement and coronary artery bypass graft presented with bioprosthetic valvefailure secondary to prosthetic valve endocarditis. This resulted in early death due to myocardial infarction and acute heartfailure.
He previously served on the HVS Board of Directors and has led the HVS AVIATOR Registry, an international registry examining outcomes after aorticvalve surgery. I am very excited and honored to lead the HeartValve Society and further consolidate its role as a unique society dedicated to valvular heart disease.
1, 2024 — Researchers at UTHealth Houston have identified genetic variants linked to a rare form of bicuspid aorticvalve disease that affects young adults and can lead to dangerous and potentially life-threatening aortic complications. tim.hodson Wed, 09/04/2024 - 15:53 Sept.
Background A quarter of patients with severe aortic stenosis (AS) were asymptomatic, and only a third of them survived at the end of 4 years. Only a select subset of these patients was recommended for aorticvalve replacement (AVR) by the current American College of Cardiology/American Heart Association guidelines.
This next-generation surgical aortic tissue valve is designed to facilitate ease of use at implant and lifetime patient management. It’s an excellent choice for cardiac surgeons and their patients seeking an aorticvalve solution that can be fit for the future, right from the start. February 18–21, 2024.
This next-generation surgical aortic tissue valve is designed to facilitate ease of use at implant and lifetime patient management. It’s an excellent choice for cardiac surgeons and their patients seeking an aorticvalve solution that can be fit for the future, right from the start. February 18–21, 2024.
milla1cf Fri, 06/07/2024 - 14:50 June 7, 2024 — Medtronic today announced new data from the CoreValve Evolut Clinical Program , reinforcing the positive performance of the Evolut transcatheter aorticvalve replacement (TAVR) System compared to surgical aorticvalve replacement (SAVR) and other TAVR valves.
This study aimed to confirm the prognostic value of a novel angiographic microvascular resistance (AMR) index in patients undergoing transcatheter aorticvalve replacement.Methods and ResultsWe prospectively included 335 patients with severe aortic stenosis who underwent transcatheter aorticvalve replacement at Fuwai Hospital.
Ad hoc subanalyses were conducted in patients with aorticvalve replacement at first diagnosis (surrogate for severe AS). in the ASonly, ATTRCAonly, and ASplusATTRCA cohorts; heartfailure hospitalization rates were 29.4% (95% CI, 29.229.5), 22.8% (95% CI, 21.923.8), and 48.7% (95% CI, 45.751.7). 95% CI, 1.11.4];P<0.0001)
The Most Common Form of HVD One of the most prevalent and serious forms of heartvalve disease is aortic stenosis (AS), a condition characterized by the narrowing of the aorticvalve opening, which affects approximately 5% of adults over 65a number expected to more than double by 2050.
New-onset persistent left bundle branch block (NOP-LBBB) at discharge after transcatheter aorticvalve replacement (TAVR) is frequent but its association with death and hospitalization for heartfailure (HHF) remains unclear.
Journal of the American Heart Association, Ahead of Print. BackgroundLp(a) (lipoprotein(a)) is an independent risk factor for calcific aorticvalve stenosis (CAVS). Whether patients with CAVS and high Lp(a) levels are at higher risk of valvular or cardiovascular events is unknown.
milla1cf Thu, 03/28/2024 - 07:30 March 28, 2024 — Medtronic plc, a global leader in healthcare technology, announced that the United States Food and Drug Administration ( FDA ) has approved the Evolut FX+ transcatheter aorticvalve replacement (TAVR) system for the treatment of symptomatic severe aortic stenosis.
HHNM will use the Allia IGS Pulse system in its cardiac electrophysiology (EP) lab to plan, guide and monitor the outcomes of electrophysiological procedures, such as cardiac ablations, cardiac catherizations, transcatheter aorticvalve replacements, balloon and coronary angioplasties and more. It’s an honor to have the U.S.’s
We organize all of the trending information in your field so you don't have to. Join thousands of users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content